CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?
CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
In October 2020, Dr. Emmanuelle Charpentier and Dr. Jennifer Doudna won the Nobel Prize in Chemistry for their pioneering work in precise genome editing using the CRISPR technology. Although CRISPR technology has developed rapidly in the last decade, there are still many uncertainties before eventual use in clinical settings. In this mini review, w...
Alternative Titles
Full title
CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a4c5d293ff28416384680775052c95f7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4c5d293ff28416384680775052c95f7
Other Identifiers
ISSN
2054-9369,2095-7467
E-ISSN
2054-9369
DOI
10.1186/s40779-020-00292-2
